In this context, previous studies have shown that NE augments the sensitivity and activity of nociceptors in the human skin predominantly by targeting α2-AR [46,47] and that spinal application of α2-AR agonists led to analgesic effects in animal models of neuropathic pain [48,49,50]. Here, ADORA2A is linked to neuropathic pain.